Neural Regeneration Research

Article	Citations
Spinal cord injury–associated disruption of the autonomic immune control: does biological sex matter?	221
Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease	213
Neuromodulation techniques for modulating cognitive function: enhancing stimulation precision and intervention effects	127
Role of mitophagy in spinal cord ischemia-reperfusion injury	84
Gut microbiota modulates oligodendrocyte lineage cell response after traumatic brain injury	84
Biomarkers for synaptic dysfunction in Alzheimer’s disease	80
Liquid biopsies in psychiatric disorders: identifying peripheral biomarkers of brain health	68
Investigation of epilepsy-related genes in a Drosophila model	60
The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury	51
Polysialic acid-Siglec immune checkpoints of microglia and macrophages: perspectives for therapeutic intervention	51
The complex role of protocadherin-19 in brain function: a focus on the oxytocin system	50
Reassessing the AMPK-MTORC1 balance in autophagy in the central nervous system	48
Extracellular vesicles drive tau spreading in Alzheimer’s disease	40
CircLphn3 protects the blood-brain barrier in traumatic brain injury	40
Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injury	39
MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer’s disease and amyotrophic lateral sclerosis	38
The dopaminergic system and Alzheimer’s disease	38
Harnessing therapeutic potential of induced pluripotent stem cell–derived endothelial cells for remyelination in the central nervous system	37
Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials	37
Modulation of the Nogo signaling pathway to overcome amyloid-β-mediated neurite inhibition in human pluripotent stem cell–derived neurites	37
Apolipoprotein E elicits target-directed miRNA degradation to maintain neuronal integrity	37
TREM2 as an evolving therapeutic target in Alzheimer’s disease	36
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	36
Neuroprotective potential for mitigating ischemia-reperfusion-induced damage	36
Quantitative proteomic and phosphoproteomic analyses of the hippocampus reveal the involvement of NMDAR1 signaling in repetitive mild traumatic brain injury	36

Liver as a new target organ in Alzheimer’s disease: insight from cholesterol metabolism and its role in amyloid-beta clearance	35
Decoding complexity: the need to enhance precision and streamline spatial understanding in neuroscience	35
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	35
Riding the rails – different modes for RNA complex transport in axons	33
Response to Letter to the Editor	33
Maintaining moderate levels of hypochlorous acid promotes neural stem cell proliferation and differentiation in the recovery phase of stroke	33
Neurovascular unit on a chip: the relevance and maturity as an advanced in vitro model	33
Investigating epithelial-neuronal signaling contribution in visceral pain through colon organoid-dorsal root ganglion neuron co-cultures	33
Neural plasticity in Parkinson’s disease: a neuroimaging perspective	32
Long noncoding RNA GAS5 acts as a competitive endogenous RNA to regulate GSK-3β and PTEN expression by sponging miR-23b-3p in Alzheimer’s disease	32
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	31
Quo vadis? Bioengineered polysaccharide-based hydrogel scaffolds for damaged central nervous system recovery and regeneration	31
Functional hyperconnectivity related to brain disease: maladaptive process or element of resilience?	31
Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease	31
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	31
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	30
Protocadherin gamma C3: a new player in regulating vascular barrier function	30
Alpha2-adrenergic receptor activation reinstates motor deficits in rats recovering from cortical injury	29
High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke	29
Resolving the age-related decline in central nervous system myelin turnover and drug discovery for oligodendroglial rejuvenation	29
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	29
In vivo direct neuronal conversion as a therapeutic strategy for ischemic stroke	28
Photobiomodulation inhibits the expression of chondroitin sulfate proteoglycans after spinal cord injury via the Sox9 pathway	28
Reevaluating the cause of laminopathy in Alzheimer’s disease	28
Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regeneration	28
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	28
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	28
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	28
Purinergic signaling systems across comparative models of spinal cord injury	27
Choroid plexus imaging to track neuroinflammation – a translational model for mouse and human studies	27
Exercise preconditioning alleviates ischemia-induced memory deficits by increasing circulating adiponectin	27
Differential response of injured and healthy retinas to syngeneic and allogeneic transplantation of a clonal cell line of immortalized olfactory ensheathing glia: a double-edged sword	27
A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury	26
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	26
The role of exosomes in adult neurogenesis: implications for neurodegenerative diseases	26
Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis	26
Angiotensin-(1–7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson’s disease	25
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	25
The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease	25
The gut microbiome: implications for neurogenesis and neurological diseases	25
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	25
Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice	24
Transforming growth factor-beta 1 enhances discharge activity of cortical neurons	24
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	24
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial	24
On implications of somatostatin in diabetic retinopathy	24
Transcription factors promote neural regeneration after spinal cord injury	23
Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers	23
Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	23
Amyloid-beta and tau protein beyond Alzheimer’s disease	23

The ferroptosis activity is associated with neurological recovery following chronic compressive spinal cord injury	23
Role of copper chelating agents: between old applications and new perspectives in neuroscience	22
Defined hydrogels for spinal cord organoids: challenges and potential applications	22
A spotlight on dosage and subject selection for effective neuroprotection: exploring the central role of mitochondria	22
Mechanisms behind elevated serum levels of plasminogen activator inhibitor-1 in frontotemporal lobar degeneration	22
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	22
Glycolytic dysregulation in Alzheimer’s disease: unveiling new avenues for understanding pathogenesis and improving therapy	22
Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity	22
Oligodendroctyes: the forgotten players of diabetes pathophysiology	22
The lymphatic drainage systems in the brain: a novel target for ischemic stroke?	22
Limitations in activities of daily living increase the risk of stroke in older Chinese adults: a population-based longitudinal study	21
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	21
Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection?	21
Corrigendum: Genistein suppresses mitochondrial apoptotic pathway in rat hippocampal neurons with Alzheimer's disease	21
NECAB family of neuronal calcium-binding proteins in health and disease	21
The dual role of striatal interneurons: circuit modulation and trophic support for the basal ganglia	21
Pathogenic and therapeutic role of exosomes in neurodegenerative disorders	21
Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury	21
Non-cell autonomous role of astrocytes in axonal degeneration of cortical projection neurons in hereditary spastic paraplegias	20
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	20
Neuropeptide cholecystokinin: a key neuromodulator for hippocampal functions	20
Microglia and astrocytes mediate synapse engulfment in a MER tyrosine kinase-dependent manner after traumatic brain injury	20
Decline and fall of aging astrocytes: the human perspective	20
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	20
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease	20
Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury	20
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	19
Spliceosomal GTPase Eftud2 regulates microglial activation and polarization	19
Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine	19
Respiratory plasticity following spinal cord injury: perspectives from mouse to man	19
Chlorogenic acid alleviates hypoxic-ischemic brain injury in neonatal mice	19
Heterogeneous patterning of blood-brain barrier and adaptive myelination as renewing key in gray and white matter	19
Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study	19
Genetic pathways in cerebral palsy: a review of the implications for precision diagnosis and understanding disease mechanisms	19
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	19
Neuroinflammation and glial activation in the central nervous system: a metabolic perspective	19
Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations	19
Complementary roles of glial cells in generating region-specific neuroinflammatory responses and phagocytosis in Parkinson’s disease	18
Aggresome-aggrephagy transition process: getting closer to the functional roles of HDAC6 and BAG3	18
Exploring the role of N-acetyltransferases in diseases: a focus on N-acetyltransferase 9 in neurodegeneration	18
Vimentin as a potential target for diverse nervous system diseases	18
Ambroxol, the cough expectorant with neuroprotective effects	18
Calcium channels caught in peripheral glia’s tug-of-war on axon regeneration in Drosophila	18
Reduced non-CpG methylation is a potential epigenetic target after spinal cord injury	18
Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson’s disease in rats	18
Advances in spinal cord injury: insights from non-human primates	18
The gut–eye axis: from brain neurodegenerative diseases to age-related macular degeneration	18
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	18
The mechanism by which hyperbaric oxygen treatment alleviates spinal cord injury: genome-wide transcriptome analysis	18
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	18
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration	17
PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives	17
Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration	17
Activation of endogenous neurogenesis and angiogenesis by basic fibroblast growth factor-chitosan gel in an adult rat model of ischemic stroke	17
Unilateral rNurr1-V5 transgene expression in nigral dopaminergic neurons mitigates bilateral neuropathology and behavioral deficits in parkinsonian rats with α-synucleinopathy	17
Correlation between cerebral cortex changes and clinical features in patients with neuromyelitis optica spectrum disorder with normal-appearing brain tissue: a case-control study	17
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	17
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	17
Advanced brain organoids for neuroinflammation disease modeling	17
A sphingolipid message promotes neuronal health across generations	16
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	16
Molecular chaperones in stroke-induced immunosuppression	16
A functional tacrolimus-releasing nerve wrap for enhancing nerve regeneration following surgical nerve repair	16
Experimental nerve transfer model in the neonatal rat	16
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	16
Mechanism by which Rab5 promotes regeneration and functional recovery of zebrafish Mauthner axons	16
Optic nerve injury-induced regeneration in the adult zebrafish is accompanied by spatiotemporal changes in mitochondrial dynamics	16
Potential application of let-7a antagomir in injured peripheral nerve regeneration	16
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	16
Focusing on the tetra-partite synapse in Parkinson’s disease research using human patient-derived neurons	16
Silk-based nerve guidance conduits with macroscopic holes modulate the vascularization of regenerating rat sciatic nerve	16
Suppression of mature TAU isoforms prevents Alzheimer's disease-like amyloid-beta oligomer-induced spine loss in rodent neurons	16
Axon degeneration: new actor in an old play	16
Amyloid-β-induced disruption of axon-initial-segment mitochondria localization: consequences for TAU missorting in Alzheimer’s disease pathology	16
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	15
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	15
The role of miRNA in retinal ganglion cell health and disease	15
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases	15
The role of crm-1 in ionizing radiation-induced nervous system dysfunction in Caenorhabditis elegans	15
Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury	15

Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	15
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	15
Role of exercise in the brain: focus on oligodendrocytes and remyelination	15
Influence of aging, mitochondrial dysfunction, and inflammation on Parkinson’s disease	15
Use of induced pluripotent stem cell-derived brain cells, organoids, assembloids, and blood-brain barrier models in understanding alcohol and anesthetic-induced brain injuries: an emerging perspective	15
Inhibition of microRNA-29b suppresses oxidative stress and reduces apoptosis in ischemic stroke	15
Axon regeneration: membrane expansion and lipidomics	15
Surgical intervention combined with weight-bearing walking training promotes recovery in patients with chronic spinal cord injury: a randomized controlled study	15
Approaches to quantify axonal morphology for the analysis of axonal degeneration	15
The dorsal root ganglion as a target for neurorestoration in neuropathic pain	15
Vagus nerve stimulation is a potential treatment for ischemic stroke	15
Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect	15
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	15
A dysregulated calcium homeostasis as the earliest pathological sign in stem cell-derived Parkinson's disease neurons?	15
Role of pituitary adenylate cyclase-activating polypeptide in peripheral nerve regeneration: a cellular and molecular perspective	15
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	15
Working toward an integrated plasticity/network framework for repetitive transcranial magnetic stimulation to inform tailored treatments	15
Conformational dynamics as an intrinsic determinant of prion protein misfolding and neurotoxicity	15
Small extracellular vesicles from hypoxia-preconditioned bone marrow mesenchymal stem cells attenuate spinal cord injury via miR-146a-5p-mediated regulation of macrophage polarization	15
Neuroinflammation as a therapeutic target in Huntington’s disease	15
Primary lateral sclerosis: more than just an upper motor neuron disease	15
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	15
Traumatic brain injury treatment using a rodent model of homelessness	15
Repetitive transcranial magnetic stimulation promotes neurological functional recovery in rats with traumatic brain injury by upregulating synaptic plasticity-related proteins	15
Using microglia-derived extracellular vesicles to capture diversity of microglial activation phenotypes following neurological injury	14
Association of DNA methylation/demethylation with the functional outcome of stroke in a hyperinflammatory state	14
Research advances on how metformin improves memory impairment in “chemobrain”	14
Clustering of voltage-gated ion channels as an evolutionary trigger of myelin formation	14
Contribution of ferroptosis and SLC7A11 to light-induced photoreceptor degeneration	14
Myeloperoxidase: a new target for the treatment of stroke?	14
Use of donepezil for neurocognitive recovery after brain injury in adult and pediatric populations: a scoping review	14
Hypothalamic circuits and aging: keeping the circadian clock updated	14
Corrigendum: MicroRNA-502-3p regulates GABAergic synapse function in hippocampal neurons	14
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	14
Aquaporin 5 in Alzheimer’s disease: a link between oral and brain pathology?	14
Modifying the progression of Parkinson's disease through movement interventions: multimodal quantification of underlying mechanisms	14
Polyethylene glycol has immunoprotective effects on sciatic allografts, but behavioral recovery and graft tolerance require neurorrhaphy and axonal fusion	14
The emerging role of mesenchymal stem cell–derived extracellular vesicles to ameliorate hippocampal NLRP3 inflammation induced by binge-like ethanol treatment in adolescence	14
Metabolic and proteostatic differences in quiescent and active neural stem cells	14
Probing the endoplasmic reticulum-mitochondria interaction in Alzheimer’s disease: searching far and wide	13
Growth associated protein 43 and neurofilament immunolabeling in the transected lumbar spinal cord of lizard indicates limited axonal regeneration	13
Role of peripheral amyloid-β aggregates in Alzheimer’s disease: mechanistic, diagnostic, and therapeutic implications	13
Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease	13
Design and redesign journey of a drug for transthyretin amyloidosis	13
A cup of coffee for a brain long life	13
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	13
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice	13
Etiology matters: genetic and acquired prion diseases engage different mechanisms at a presymptomatic stage	13
Enriched environment for offspring improves learning and memory impairments induced by sevoflurane exposure during the second trimester of pregnancy	13
Tandem Mass Tag-based proteomics analysis reveals the vital role of inflammation in traumatic brain injury in a mouse model	13
Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis	13
Effect of caffeine in the intraventricular hemorrhage of the preterm newborn	13
cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?	13
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	13
Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?	13
Thrombin increases the expression of cholesterol 25-hydroxylase in rat astrocytes after spinal cord injury	13
ATAT1 deficiency enhances microglia/macrophage-mediated erythrophagocytosis and hematoma absorption following intracerebral hemorrhage	13
Enhancement of endogenous midbrain neurogenesis by microneurotrophin BNN-20 after neural progenitor grafting in a mouse model of nigral degeneration	13
A simple human cell model for TAU trafficking and tauopathy-related TAU pathology	13
Ultra-early amplitude decrement after repetitive nerve stimulation supports early neuromuscular junction injury in amyotrophic lateral sclerosis: a prospective cross-sectional study	13
Cyclophilin D-induced mitochondrial impairment confers axonal injury after intracerebral hemorrhage in mice	13
Role of metabolic dysfunction and inflammation along the liver–brain axis in animal models with obesity-induced neurodegeneration	13
Telomerase and neurons: an unusual relationship	13
A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G	13
Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update	13
Substrate topography as a powerful tool to modify glial cell biology and interactions	13
Cell-type resolved transcriptomic approaches for dissecting selective vulnerability in neurodegeneration	12
Mice lacking perforin have improved regeneration of the injured femoral nerve	12
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets	12
Plasticity of callosal neurons in the contralesional cortex following traumatic brain injury	12
Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease	12
AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice	12
Piezo1 suppression reduces demyelination after intracerebral hemorrhage	12
NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality	12
Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson’s disease	12
Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?	12
Pathology-induced NG2 proteoglycan expression in microglia	12
From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic pain	12
Is it possible to develop a cerebellar reserve?	12
Neurogenic potential of NG2 in neurotrauma: a systematic review	12
Microglial autophagy in neurogenesis: a new player in Alzheimer’s disease	12
Mitochondrial dysfunction and quality control lie at the heart of subarachnoid hemorrhage	12
Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement	12
Patient-specific monocyte-derived microglia as a screening tool for neurodegenerative diseases	12
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings	12
On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics	12
Inhibiting phosphatase and actin regulator 1 expression is neuroprotective in the context of traumatic brain injury	12
Hemorrhagic transformation in patients with large-artery atherosclerotic stroke is associated with the gut microbiota and lipopolysaccharide	12
Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option	12
Long non-coding RNA MEG3 regulates autophagy after cerebral ischemia/reperfusion injury	12
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	12
Tilting homeostatic and dyshomeostatic microglial balance in health and disease: transforming growth factor-beta1 as a critical protagonist	11
Amyloid-beta pathology–induced nanoscale synaptic disruption: the case of the GABAB–GIRK assembly	11
The physiological role of the unfolded protein response in the nervous system	11
Sustained release of vascular endothelial growth factor A and basic fibroblast growth factor from nanofiber membranes reduces oxygen/glucose deprivation-induced injury to neurovascular units	11